The role of the novel interface cell state in melanoma invasion
Project Number5K99CA266931-02
Former Number1K99CA266931-01
Contact PI/Project LeaderHUNTER, MIRANDA VICTORIA
Awardee OrganizationSLOAN-KETTERING INST CAN RESEARCH
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Candidate: I am a postdoctoral fellow in the laboratory of Dr. Richard White at Memorial Sloan Kettering
Cancer Center. My research career has focused on how cells interact and communicate, beginning with my
PhD research into how skin cells coordinate rapid wound healing in the embryonic epidermis, and continuing
into my postdoctoral research on how tumor and microenvironment cells interact during melanoma invasion.
My recent publication uncovered a novel “interface” cell state adopted by both tumor and microenvironment
cells at the tumor boundary, distinguished by upregulation of cilia. The objective of this proposal is to determine
the contribution of the cilia-enriched interface cell state to melanoma invasion. Ultimately, my long-term goal is
to lead an independent group studying how tumor and microenvironment cells cooperate to promote
melanoma progression. To accomplish these goals, I have developed a career plan to: (1) develop new
scientific and technical skills; (2) become an effective leader and mentor; (3) extend my professional network of
advisors and collaborators; (4) successfully transition to an independent role.
Research: Recent advances in treating melanoma, including targeted therapies and immunotherapy,
demonstrate how an understanding of the molecular mechanisms of melanoma progression and the role of the
tumor microenvironment (TME) can lead to novel therapeutics. Interactions between tumor and TME cells
often promote melanoma progression. My recent work identified a novel cilia-enriched “interface” cell state
adopted by tumor and microenvironment cells at the tumor boundary, and found that cilia are required for
melanoma invasion. This indicates that the interface cell state may have a critical role in melanoma
progression. To investigate the role of the interface in invasion, I will accomplish the following specific aims: (1)
determine the mechanism by which cilia promote invasion; (2) investigate how cilia gene expression is
regulated; (3) identify the mechanisms that establish the interface cell state.
Environment: During the mentored phase, the proposed work will be completed at Memorial Sloan Kettering
Cancer Center (MSKCC), one of the world’s leading cancer centers with a history of major discoveries in
cancer biology. The research will be performed in the White laboratory within Sloan Kettering Institute, the
research arm of MSKCC, led by Dr. Joan Massagué. The White laboratory is a member of the Cancer Biology
and Genetics Program within Sloan Kettering Institute, a program led by my co-mentor Dr. Scott Lowe.
Between my mentor, co-mentor, advisory committee, and collaborators, I have assembled an outstanding team
of experts in basic and translational cancer research who will guide this work and assist with achieving my
scientific and professional goals during the transition to independence.
Public Health Relevance Statement
PROJECT NARRATIVE
Tumor and microenvironment cells often interact to promote cancer progression, but gaps remain in our
understanding of how these interactions occur. My recent publication uncovered a novel cilia-enriched
“interface” cell state adopted by both tumor and microenvironment cells in melanoma, indicating that the
interface may have a critical role in melanoma progression. My proposed work will investigate how the
interface is established and how it contributes to invasion, and could provide novel therapeutic targets to
prevent melanoma progression.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdipocytesAdoptedAdvisory CommitteesBasic Cancer ResearchBiological ModelsCancer BiologyCancer CenterCell CommunicationCellsChromatinChromatin Remodeling FactorCiliaCleavage Under Targets and Release Using NucleaseComplementCoupledDataDoctor of PhilosophyEmbryoEnsureEnvironmentEpidermisEpigenetic ProcessFamilyFibroblastsGene ExpressionGenesGeneticGoalsGrowthHMGB2 geneHallmark CellHumanHuman Cell LineImaging DeviceImmuneImmunotherapyIn VitroIndividualInvadedLaboratoriesLeadMediatingMelanomaMemorial Sloan-Kettering Cancer CenterMentorsMetastatic MelanomaMicroscopyModelingMolecularPhasePostdoctoral FellowProliferatingPublicationsRecording of previous eventsResearchRoleSHH geneSignal TransductionSkinSurvival RateSystemTechnical ExpertiseTissuesTransforming Growth Factor betaTumor PromotionUp-RegulationWorkZebrafisharmcancer geneticscareercareer networkingcell behaviorcell typeclinically relevantcombatexperimental studyfollow-uphuman diseaseimprovedin vivomemberneoplastic cellnew therapeutic targetnotch proteinnovelnovel therapeuticspreventprogramssingle-cell RNA sequencingspatial integrationsuccesstargeted treatmenttherapeutic targetthree dimensional cell culturetranscription factortranscriptional reprogrammingtranscriptomicstranslational cancer researchtumortumor growthtumor microenvironmenttumor progressionwound healing
No Sub Projects information available for 5K99CA266931-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K99CA266931-02
Patents
No Patents information available for 5K99CA266931-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K99CA266931-02
Clinical Studies
No Clinical Studies information available for 5K99CA266931-02
News and More
Related News Releases
No news release information available for 5K99CA266931-02
History
No Historical information available for 5K99CA266931-02
Similar Projects
No Similar Projects information available for 5K99CA266931-02